• DOI:10.1177/106002808201600212
Corpus ID: 20968675

Acquired Methemoglobinemia and Hemolytic Anemia after Usual Doses of Phenazopyridine

@inproceedings{Jeffery1982AcquiredMA,
  title={Acquired Methemoglobinemia and Hemolytic Anemia after Usual Doses of Phenazopyridine},
  author={W. H. Jeffery and A. Zelicoff and W. R. Hardy},
  booktitle={Drug intelligence & clinical pharmacy},
  year={1982}
}

W. H. Jeffery, A. Zelicoff, W. R. Hardy

Published in

Drug intelligence & clinical…

1982

Medicine

Two patients developed symptomatic methemoglobinemia and hemolytic anemia after treatment with phenazopyridine. Methemoglobinemia appears to be a rare occurrence after commonly used doses of phenazopyridine; phenazopyridine-associated hemolytic anemia has been reported both after overdose and after usual doses. The presentation of methemoglobinemia in the first patient and the response to treatment with methylene blue in the second patient were unusual, suggesting that the patients had a red… CONTINUE READING

View on SAGE

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed